The Trump administration has launched military strikes in Syria to “eliminate” Islamic State group fighters and weapons sites in retaliation for an ambush attack that killed two U.S. troops and an ...

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

President Trump announced deals with nine major drug makers in a move to reduce pharmaceutical prices, granting a three-year ...

The Marine Corps will institute a sex-neutral scoring physical fitness test for Marines with a combat arms primary military ...

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Amgen, Bristol Myers Squibb, Boehringer Ingelheim, ...

Nine drugmakers are set to unveil deals with the Trump administration to lower the prices of some of their drugs, marking the ...

In the U.S. there are more than 150 million emergency department (ED) visits each year, and the number is expected to rise. ED physicians face enormous pressure to quickly and correctly diagnose ...

The deal announced Friday tacks on to similar reduced price agreements the Trump administration has made with five other ...

In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with ...

After 27 years in business, Cytokinetics hopes to pit its own cardiac myosin inhibitor against one it initially developed—now owned by Bristol Myers Squibb—in a market worth billions. Aficamten has a ...